Antibiotic

Pyrrocidine A is an antibiotic that exhibits notable antibacterial activity, derived from LL-Cyan426. This compound targets various bacterial strains, making it a valuable reagent for research focused on bacterial infections and antibiotic development. Its unique mechanism of action offers potential insights into novel therapeutic strategies against antibiotic-resistant pathogens.

Monamycin D1 is an ester peptide antibiotic that targets Gram-positive bacteria. This compound exhibits potent antibacterial activity, making it a valuable tool for research applications focused on bacterial pathogenesis and antibiotic resistance. Its efficacy in inhibiting Gram-positive strains provides insights into antibiotic mechanisms and potential therapeutic strategies.

Cervicarcin is an antitumor antibiotic that predominantly targets cancerous cells through its potent inhibitory action. It exhibits significant cytotoxicity against sarcoma 180 and sarcoma NF, while demonstrating a lesser impact on sarcoma 37, Ehrman's ascites cancer, and Friend leukemia. This compound is valuable for research applications focused on investigating tumor biology and evaluating therapeutic strategies for various sarcomas.

Memnobotrin A is an antitumor antibiotic derived from Memnoniella echinata (JS6308). This compound exhibits significant inhibitory effects on various cancer cell lines, including NCI-460, MCF7, and SF-268. It serves as a valuable tool for research applications focused on elucidating mechanisms of cancer cell growth and resistance.

Pluracidomycin C3 is a carbapenem antibiotic that exhibits potent activity against both Gram-positive and Gram-negative bacteria. This compound disrupts bacterial cell wall synthesis, making it a valuable tool in the study of antibiotic resistance mechanisms. Its efficacy in various bacterial models supports its use in researching novel antimicrobial therapies and evaluating susceptibility patterns in pathogenic strains.

2-Hydroxygentamicin B is a 3 aminoglycoside antibiotic that exerts its action by inhibiting bacterial protein synthesis. It demonstrates significant antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is used in microbiological research to explore mechanisms of antibiotic resistance and the efficacy of various treatment regimens.

Tobramycin (monosulfate) is a broad-spectrum aminoglycoside antibiotic primarily targeting bacterial ribosomes to inhibit protein synthesis. It exhibits potent antibacterial activity against a range of gram-negative bacteria, particularly Pseudomonas aeruginosa, making it valuable in the treatment of moderate to severe infections. Tobramycin monosulfate is commonly utilized in research to investigate pneumonia and other infections caused by susceptible organisms.

Asparenomycin A is a carbapenem antibiotic that effectively inhibits β-lactamase enzymes. This compound demonstrates potent antibacterial activity, making it valuable for research into antibiotic resistance and the development of novel therapeutic strategies. Its mechanism of action and strong efficacy against resistant bacterial strains support its application in microbiological studies and drug development initiatives.

Nanaomycin D is an antibiotic that targets bacterial cell processes to exert its antibacterial activity. It effectively inhibits the growth of various bacterial strains, making it a valuable tool for microbiological studies. Researchers can use Nanaomycin D to investigate bacterial resistance mechanisms and the efficacy of antimicrobial agents in treating bacterial infections.

Coumamidine γ1 is a potent alkaline sugar antibiotic that targets bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity, including significant efficacy against Pseudomonas aeruginosa. This compound is valuable for research applications focused on combating antibiotic-resistant pathogens and studying bacterial resistance mechanisms.

8-Hydroxyerythromycin A is a semi-synthetic antibiotic primarily targeting bacterial infections. This compound exhibits significant antibacterial activity, making it valuable in the study of mechanisms of antibiotic resistance and in the development of new therapeutic strategies. It is applicable in various research fields, including microbiology and pharmacology, where understanding antibiotic efficacy is essential.

Ibafloxacine is a fluoroquinolone antibiotic designed primarily for veterinary applications. It functions by inhibiting bacterial DNA gyrase and topoisomerase IV, leading to the disruption of DNA replication and transcription in susceptible organisms. Its key biological activity includes effective treatment against various bacterial infections in animals, making it a valuable tool for veterinary medicine research and development.

Tigemonam is a monobactam antibiotic that targets β-lactamase enzymes, demonstrating a Ki of 0.86 μM against Enterobacter cloacae P99 and 50.8 μM against Escherichia coli TEM-1. It binds to penicillin-binding proteins 1a, 3, and 4, effectively inhibiting bacterial cell wall synthesis and exhibiting bactericidal activity against a range of aerobic gram-negative bacteria, including Enterobacteriaceae, Haemophilus influenzae, and Neisseria gonorrhoeae. Tigemonam is resistant to hydrolysis by multiple β-lactamases and has been shown to reduce bacterial load in systemic and localized infections in rodent models. This compound is valuable for research into gram-negative bacterial infections, particularly acute pyelonephritis, lung infections, and thigh muscle infections.

Tauroxicum is an antibiotic substitute that functions as a non-toxic, non-antimicrobial agent. It has been shown to enhance the health, productivity, feed efficiency, and weight gain of livestock animals. This reagent serves as a valuable tool in animal husbandry, offering a means to support livestock welfare while potentially reducing reliance on traditional antibiotics.

PK150, an analogue of Sorafenib, is an antibiotic that demonstrates oral bioavailability and effective antibacterial activity against multiple pathogenic bacterial strains at submicromolar concentrations. Notably, PK150 exhibits inhibitory effects on Gram-positive bacteria, including Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin intermediate Staphylococcus aureus (VISA), with minimum inhibitory concentrations (MICs) of 0.3 μM for MSSA and 0.3-1 μM for MRSA and VISA. This compound is suitable for research applications aimed at understanding bacterial resistance and developing novel antimicrobial therapies.

Cefditoren is an orally active antibiotic that exhibits broad-spectrum antibacterial activity against both Gram-negative and Gram-positive bacteria. It demonstrates a MIC50 of 0.25-0.5 mg/L against Streptococcus pneumoniae strains. Cefditoren is primarily utilized in the treatment of respiratory tract infections and skin infections, making it a valuable tool in infectious disease research.

Cadrofloxacin is an orally active fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV, leading to inhibition of bacterial DNA replication. It demonstrates efficacy against a wide range of both aerobic and anaerobic Gram-positive and Gram-negative bacteria. This compound is useful for research applications focused on combating infectious diseases and studying bacterial resistance mechanisms.

LpxH-IN-AZ1 is a sulfonyl piperazine compound that functions as a potent inhibitor of UDP-2,3-diacylglucosamine pyrophosphate hydrolase (LpxH). This compound demonstrates significant inhibitory activity against Klebsiella pneumoniae LpxH, achieving an IC50 value of 0.36 μM. LpxH-IN-AZ1 is valuable for research applications targeting antibiotic drug development and bacterial resistance mechanisms.

Sulfanitran is a sulfonamide antibiotic that serves as an antibacterial and anticoccidial agent, particularly in poultry feed formulations. This compound functions as a stimulator of multidrug resistance protein 2 (MRP2), enhancing its affinity for estradiol-17-β-D-glucuronide (E217βG). It is utilized in research applications focused on antibiotic resistance and the modulation of drug transport mechanisms.

LAH4 is an amphipathic peptide antibiotic characterized by its alpha-helical structure. It demonstrates potent antimicrobial properties, along with effective nucleic acid transfection and enhanced cell penetration capabilities. LAH4 shows a strong affinity for anionic lipids present in the outer membranes of bacteria, making it a valuable tool for plasmid DNA delivery in various research applications.

Sulfadiazine-d4 is a deuterium-labeled variant of the sulfonamide antibiotic sulfadiazine, which primarily targets dihydropteroate synthase to inhibit bacterial folate synthesis. This compound is utilized in research applications involving the investigation of sulfonamide pharmacokinetics, metabolism, and its effects on bacterial infection models, particularly toxoplasmosis. The stable isotope labeling allows for enhanced monitoring and analysis in various biochemical assays.

Cefaloglycin is a nephrotoxic β-lactam cephalosporin antibiotic that exhibits significant antibacterial activity, specifically targeting Gram-positive cocci, excluding enterococci. Its mechanism involves inhibition of bacterial cell wall synthesis, making it effective in clinical settings requiring treatment of specific bacterial infections. Additionally, Cefaloglycin has been shown to interfere with mitochondrial substrate uptake and respiration, adding to its profile as a compound of interest in biochemical and pharmacological research.

Micrococcin P1 is a macrocyclic peptide antibiotic exhibiting significant antiviral and antibacterial activity. Its primary mechanism involves the inhibition of hepatitis C virus (HCV) replication, with an EC50 range of 0.1-0.5 μM. Additionally, Micrococcin P1 demonstrates in vitro antibacterial efficacy against Gram-positive bacteria, with MIC values of 2 μg/mL for Staphylococcus aureus, 1 μg/mL for Enterococcus faecalis, and 1 μg/mL for Streptococcus pyogenes. Furthermore, it is an effective inhibitor of the malaria parasite Plasmodium falciparum, making it valuable for diverse research applications in infectious diseases.

Malacidin B is a macrocyclic lipopeptide antibiotic that exerts its antibacterial effects through a calcium-dependent mechanism. It has demonstrated significant activity against a range of Gram-positive bacteria, making it a valuable tool for researchers studying antibiotic resistance and developing new antimicrobial therapies. Its unique structure and mechanism of action provide avenues for exploring novel treatments in bacterial infections.

M 14659 is a semisynthetic cephalosporin antibiotic with potent antimicrobial activity. It exhibits strong inhibitory effects against Gram-negative bacteria, notably Pseudomonas aeruginosa. This compound is applicable in research focused on antibiotic resistance and the development of novel therapeutic strategies for bacterial infections.

Cefpodoxime proxetil impurity B is a key impurity associated with Cefpodoxime proxetil, a third-generation cephalosporin antibiotic. This compound exhibits antibacterial activity, primarily targeting bacterial cell wall synthesis. It serves as an important reference standard in pharmaceutical research and development for quality control and analytical studies evaluating the purity of Cefpodoxime proxetil formulations.

Erythromycin gluceptate is a macrolide antibiotic that targets bacterial 50S ribosomal subunits, inhibiting RNA-dependent protein synthesis through the blockade of transpeptidation and translocation reactions. Its broad spectrum of antimicrobial activity makes it suitable for diverse bacteriological studies. In addition to its primary antibiotic function, erythromycin gluceptate has demonstrated antitumor and neuroprotective properties, providing valuable opportunities for research in oncology and neurobiology.

BO-1236 is an antibiotic compound that exhibits potent antibacterial activity, particularly against Gram-negative bacteria, including Pseudomonas aeruginosa. This compound demonstrates in vitro and in vivo efficacy that is either superior to or comparable with some standard antibiotics. Additionally, BO-1236 shows stability against β-lactamase, making it a valuable tool for research applications targeting bacterial infections.

Deacetylravidomycin N-oxide is an antibiotic derived from Streptomyces ravidus S50905, primarily targeting Gram-positive bacteria while exhibiting no activity against Gram-negative strains. This compound demonstrates significant antitumor effects, particularly against P388 leukemia and methamphetamine A fibrosarcoma models. Its biological properties make it a valuable tool for research in microbiology and cancer studies.

Drimentine C is a terpenylated diketopiperazine antibiotic that targets bacterial proliferation. This compound demonstrates significant cytotoxicity, inhibiting the growth of NS-1 murine β lymphocyte myeloma cells by 63% and 98% at concentrations of 12.5 μg/mL and 100 μg/mL, respectively. Drimentine C can be utilized in research focused on antibiotic mechanisms and the evaluation of antitumor activities.

Glycocinnasperimicin D is an antitumor antibiotic that functions as a glycoside cinnamyl imide histamine derivative. It demonstrates significant antimicrobial activity against both Gram-positive and Gram-negative bacteria. Furthermore, Glycocinnasperimicin D exhibits potent cytotoxicity against leukemia L1210 cells, with an IC50 value of 2.0 μg/mL, making it a valuable compound for research in cancer biology and antibiotic efficacy studies.

Loracarbef is a synthetic beta-lactam antibiotic belonging to the carbacephem class, exhibiting potent activity against a broad range of gram-positive and gram-negative bacteria. As an orally active, second-generation cephalosporin, Loracarbef is utilized in clinical settings for the treatment of various bacterial infections. Its mechanism involves inhibiting bacterial cell wall synthesis, making it an important agent in antibiotic research and therapeutic applications.

Xanthoquinodin A1 is an anticoccidial antibiotic that features a novel xanthone-anthraquinone conjugate system. This compound exhibits potent activity against Eimeria spp., making it valuable for research related to coccidiosis management in livestock and poultry. Its unique structure allows for exploration in studies of antibiotic resistance and potential therapeutic applications in veterinary medicine.

Tosufloxacin is a fluoroquinolone antibiotic that exerts its primary action by inhibiting bacterial DNA gyrase and topoisomerase IV. It demonstrates a broad spectrum of antibacterial activity against both gram-positive and gram-negative bacteria. Tosufloxacin is utilized in research applications aimed at studying bacterial infections and antibiotic resistance mechanisms.

Polymyxin B2 Sulfate is a polypeptide antibiotic that exerts its antibacterial effects primarily against gram-negative bacteria. Its mechanism of action involves binding to lipopolysaccharide molecules on the bacterial cell membrane, leading to membrane disruption and leakage of cellular contents. This compound is valuable in antibiotic development and the treatment of drug-resistant bacterial strains.

Bactobolin is a potent antibiotic that targets multiple bacterial strains, including Escherichia coli, Salmonella, Shigella, Staphylococcus, and Bacillus subtilis, exhibiting minimum inhibitory concentrations (MICs) ranging from 0.3 to 6.25 μg/mL. In addition to its antibacterial properties, Bactobolin demonstrates antitumor activity against leukemia, with a lethal dose 50 (LD50) value ranging from 6.25 to 12.5 mg/kg. This dual functionality makes Bactobolin a valuable compound for research in both microbiology and oncology.

Carumonam disodium is a potent antibiotic that primarily targets bacterial cell wall synthesis, rendering it effective against a range of Gram-negative pathogens. This compound exhibits significant antibacterial activity, making it suitable for research applications focused on infectious disease treatment and antibiotic resistance mechanisms. However, caution is advised as Carumonam disodium has been reported to induce seizure activity in certain conditions.

Hordenine sulfate is a bioactive compound primarily known for its antibiotic properties. It exhibits significant melanin-inhibiting activity by reducing intracellular cAMP levels and decreasing melanin content. Hordenine sulfate effectively downregulates the expression of key proteins involved in melanogenesis, such as microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related proteins (TRP-1 and TRP-2). This makes Hordenine sulfate a valuable reagent for research in dermatological studies focusing on pigmentation and related disorders.

Clindamycin Sulfoxide is an active metabolite of the antibiotic clindamycin, primarily generated through S-oxidation via the cytochrome P450 isoform CYP3A4. This compound exhibits significant antibacterial activity, effectively inhibiting the growth of anaerobic bacteria, including Peptostreptococcus prevotti, Bacteroides fragilis, and Clostridium sordelli, with minimal inhibitory concentration (MIC) values of 2 mg/L, 2 mg/L, and 1 mg/L, respectively. Clindamycin sulfoxide serves as a valuable tool for research applications focused on antibiotic efficacy and resistance mechanisms.

A83586C is a novel peptide antibiotic that specifically targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable tool for studying bacterial infections and developing new therapeutic strategies. Its unique mode of action allows researchers to explore mechanisms of resistance and efficacy in various biological contexts.

Macrosphelide A is a macrolide antibiotic that exhibits potent antimicrobial activity against a range of fungal pathogens, including ascomycetes, basidiomycetes, and oomycetes. It effectively inhibits the growth of all tested Gram-positive bacteria, including the clinically relevant Staphylococcus aureus, with a minimum inhibitory concentration (MIC) of ≤500 μg/mL. This compound is valuable for research applications aimed at exploring new antibacterial and antifungal therapeutics.

Antibiotic A40104A is an antimicrobial agent that targets bacterial cell wall synthesis. It demonstrates significant antibacterial activity against a broad spectrum of gram-positive and gram-negative organisms. This compound is suitable for use in microbiological research, including studies on antibiotic resistance mechanisms and the development of new antibacterial therapies.

Dihydrostreptomycin (DHSM) is an aminoglycoside antibiotic that primarily targets Gram-negative bacteria. It demonstrates significant antibacterial activity and is commonly utilized in research focused on the mechanisms of antibiotic resistance. Due to its ototoxic effects, which can cause irreversible damage to inner ear hair cells, it serves as a valuable model for investigating hearing loss and its underlying biological pathways.

Nanaomycin αA is an antibiotic known for its antimicrobial activity. Isolated from the fermentation broth of Streptomyces hebeiensis, this compound exhibits efficacy against various bacterial strains. Its unique properties make it valuable for research applications in microbiology and the development of new antibacterial agents.

Quinaldopeptin is a quinomycin antibiotic derived from the culture of Streptoverticillium album that exhibits significant activity against Gram-positive bacteria and anaerobic pathogens. In addition to its antibacterial properties, Quinaldopeptin demonstrates potent cytotoxic effects on cultured B16 melanoma cells. This compound is valuable for research applications focusing on antimicrobial resistance and cancer therapeutics.

A-39183A is a potent antibiotic that exerts significant cytotoxic effects on HeLa cells, demonstrated by an IC50 value of 1.8 μM. This compound's mechanism of action may offer valuable insights into antimicrobial properties and cellular response pathways. A-39183A is suitable for research applications focused on studying antibiotic resistance and cell viability in cancer models.

Baquiloprim is an antibiotic that selectively inhibits bacterial dihydrofolate reductases. It demonstrates in vitro bacteriostatic activity against a variety of both Gram-negative and Gram-positive bacteria. Baquiloprim is utilized in research applications focused on understanding bacterial resistance and the mechanisms of folate metabolism in microbial pathogens.

Alcindoromycin is an anthracycline antitumor antibiotic that exerts its effects primarily through the inhibition of topoisomerase II and intercalation into DNA. This compound demonstrates significant cytotoxic activity against various cancer cell lines, making it a valuable tool in cancer research. Alcindoromycin is utilized to investigate the mechanisms of chemoresistance and to evaluate potential therapeutic strategies for various malignancies.

Albomycin δ1 is a selective antibiotic that targets bacterial ribosomes, demonstrating bactericidal activity through covalent binding to 70S ribosomes and irreversible inhibition of peptidyl transferase. With an MIC of 0.0625 μg/mL against Streptococcus pneumoniae, this compound shows potential for research into infections caused by S. pneumoniae and Staphylococcus aureus. Its unique mechanism of action makes Albomycin δ1 a valuable tool in the study of ribosome-targeted therapeutics.

Actagardin is a tetracyclic lantibiotic that effectively targets Gram-positive bacteria by inhibiting peptidoglycan synthesis. This compound is characterized by its unique macrocyclic structure, formed through thioether bridges. Actagardin is utilized in research for its antibiotic properties, providing insights into bacterial resistance mechanisms and potential therapeutic applications.